Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 3:27 PM
Ignite Modification Date:
2025-12-24 @ 3:27 PM
NCT ID:
NCT04019392
Eligibility Criteria:
Inclusion Criteria:
* Subjects will be both male and female.
* Subjects will be between 18 and 40 years of age.
* Subjects will have no prior injury to the dominant lower leg within the past 6 months.
* Subjects will be able to speak English.
* Subjects will have less than 1 cm of adipose over the medial gastrocnemius muscle.
Exclusion Criteria:
* any current lower extremity injury, or any lower extremity injuries within the past 6 months.
* any previous history of surgery in the lower leg
* any contraindications to cryotherapy such as Raynaud's phenomenon, cold-induced urticaria, previous frostbite to the lower leg, open wounds, peripheral vascular disease, lupus, circulatory insufficiency, mayocardial ischemia, or skin infections.
* any abnormalities seen in the muscle as determined by diagnostic ultrasound.
* any allergies or sensitivities to Betadine.
* greater than 1.0cm of adipose over the medial gastrocnemius muscle (calf).
Healthy Volunteers:
True
Sex:
ALL
Minimum Age:
18 Years
Maximum Age:
40 Years
Study:
NCT04019392
Study Brief:
Protocol Section:
NCT04019392